Therapeutic genome editing in cardiovascular diseases is a research paper published in Advanced Drug Delivery Reviews (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 17MERIT33610009
Burroughs Wellcome Fund
Grant: 1015009
National Institutes of Health
Grant: U01 EB021240
National Institutes of Health
Grant: R01 HL145676
National Institutes of Health
Grant: R01 HL146690
National Institutes of Health
Grant: R01 HL141851
National Institutes of Health
Grant: R01 HL 126527
NHLBI NIH HHS
Grant: R01 HL113006
NHLBI NIH HHS
Grant: R01 HL130020
National Institutes of Health
Grant: 5R01HL126527-04
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
National Institutes of Health
Grant: 5R01HL141851-07
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
National Institutes of Health
Grant: 2R01HL145676-05
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation
National Institutes of Health
Grant: 5U01EB021240-03
Hi-resolution dynamic imaging of chromosomes in single cells by combined CRISPR imaging and sequential FISH
National Institutes of Health
Grant: 1R01HL146690-01
Genetic and Stem Cell Model of Cardiac Metabolic Disease
Japan Society for the Promotion of Science
FWCI
1.79
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals